August 2008

A misleading ECG

September 02, 2008

Lipids

A 10-year-old girl was brought to her primary care provider by her mother because she complained of chest pain earlier that morning. She also reported abdominal pain and nausea.

Drug-eluting stents: Weighing the pros and cons of this therapy and its alternatives

September 01, 2008

Lipids

SORT OUT II trial results support our current understanding of drug-eluting stent use: (1) there is no difference in efficacy or safety among different drug-eluting stents; (2) stent thrombosis rates are highest in the first month after stent implantation; and (3) late stent thrombosis rates are low and not influenced by discontinuation of clopidogrel therapy at 12 months.

The SORT OUT II trial: Updated summary with a special focus on stent thrombosis and discontinuation of dual antiplatelet therapy after 1 year

August 31, 2008

Lipids

The SORT OUT II trial showed that the first generation of drug-eluting stents, Cypher® and Taxus®, exhibit similar efficacy and safety when used for percutaneous coronary intervention in everyday practice, including in a high proportion of off-label situations.

How do cardiac and noncardiac conditions affect survival after ICD implantation?

August 28, 2008

Lipids

The benefits of implantable cardioverter-defibrillators (ICDs) have been shown in randomized clinical trials. The factors that affect the risk–benefit ratio in a community setting, however, have not been evaluated.

An ounce of prevention is worth a pound of cure...

August 27, 2008

Lipids

According to the World Health Organization,about 30% of deaths worldwide result from cardiovascular diseases, many of which may be preventable by modifying or treating risk factors, such as unhealthy diet, smoking, and diabetes.

New Framingham Heart Study global cardiovascular risk instruments for use in primary prevention of atherosclerotic events

August 27, 2008

Lipids

Cardiovascular risk factors vary somewhat for each specific atherosclerotic cardiovascular disease event; however, there is sufficient commonality to enable crafting of a global CVD risk-assessment instrument that accurately predicts total CVD risk and the risk of its individual components.

New Framingham Heart Study global cardiovascular risk instruments: Helping physicians optimize their patients' cardiovascular care

August 27, 2008

Lipids

While most patients are concerned about their risk for myocardial infarction, it is important to remember that the risk factors for death from all cardiovascular diseases, including stroke, peripheral arterial disease, and coronary artery disease, are similar.